Deutsche Bank Ag\ Abb Vie Inc. Put Options Transaction History

Deutsche Bank Ag\

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $19,186 - $24,006	-266 Reduced 89.86%	30 $2,000
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $2,834 - $3,407	45 Added 17.93%	296 $22,000
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $13,576 - $15,979	176 Added 234.67%	251 $20,000
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $203,110 - $250,490	-2,609 Reduced 97.21%	75 $6,000
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $217,806 - $257,713	2,426 Added 940.31%	2,684 $248,000
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $18,402 - $24,642	200 Added 344.83%	258 $23,000
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $56,691 - $62,166	-633 Reduced 91.61%	58 $5,000
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $48,266 - $61,651	691	691 $61,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.